SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Noemí Reguart

Noemí Reguart

Hospital Clínic de Barcelona, Barcelona

Dr. Noemí Reguart is a thoracic medical oncologist at Hospital Clínic de Barcelona, Spain, where she heads the Thoracic Tumours Unit and serves as Associate Professor at the University of Barcelona. Her work combines clinical care of lung cancer patients with translational research on genomic biomarkers and targeted therapies in non-small cell lung cancer, and she is a principal investigator on numerous international clinical trials spanning EGFR-, ALK-, and MET-altered disease. She co-chaired the IASLC 2025 World Conference on Lung Cancer in Barcelona and is a frequent speaker at major international thoracic oncology congresses.

Connect

Noemí Reguart

Featured in

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates